Literature DB >> 15025942

Thioredoxin regulation of ischemic preconditioning.

Dipak K Das1.   

Abstract

Thioredoxins are a class of small redox-regulating proteins that appear to play a crucial role in many oxidative stress-inducible degenerative diseases. A recent study demonstrated a reduction of thioredoxin-1 (Trx1) protein in the ischemic reperfused myocardium. When the same heart was adapted to ischemic stress by preconditioning with repeated cyclic episodes of small duration of ischemia and reperfusion, there was an increased induction of Trx1 expression. Inhibition of Trx1 expression resulted in reduced postischemic ventricular recovery and increased myocardial infarct size in the preconditioned heart. Corroborating these findings, transgenic mouse hearts overexpressing Trx1 were resistant to ischemic reperfusion injury as compared with the hearts from wild-type mice. Thus, it appears that thioredoxin plays a crucial role in cardioprotection induced by preconditioning.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15025942     DOI: 10.1089/152308604322899477

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  13 in total

1.  Methylglyoxal increases cardiomyocyte ischemia-reperfusion injury via glycative inhibition of thioredoxin activity.

Authors:  Xiao-Liang Wang; Wayne B Lau; Yue-Xing Yuan; Ya-Jing Wang; Wei Yi; Theodore A Christopher; Bernard L Lopez; Hui-Rong Liu; Xin-Liang Ma
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-05-11       Impact factor: 4.310

Review 2.  Modulation of signaling mechanisms in the heart by thioredoxin 1.

Authors:  Narayani Nagarajan; Shinichi Oka; Junichi Sadoshima
Journal:  Free Radic Biol Med       Date:  2016-12-16       Impact factor: 7.376

Review 3.  Thioredoxin and ventricular remodeling.

Authors:  Tetsuro Ago; Junichi Sadoshima
Journal:  J Mol Cell Cardiol       Date:  2006-09-26       Impact factor: 5.000

Review 4.  Application of recombinant thioredoxin1 for treatment of heart disease.

Authors:  Shouji Matsushima; Daniela Zablocki; Junichi Sadoshima
Journal:  J Mol Cell Cardiol       Date:  2010-10-16       Impact factor: 5.000

5.  Hydrogen peroxide-induced Akt phosphorylation regulates Bax activation.

Authors:  Mahdieh Sadidi; Stephen I Lentz; Eva L Feldman
Journal:  Biochimie       Date:  2009-02-06       Impact factor: 4.079

6.  Human TRP14 gene homologue from amphioxus Branchiostoma belcheri: identification, evolution, expression and functional characterization.

Authors:  Shengjuan Jiang; Shicui Zhang; Verapong Vuthiphandchai; Subuntith Nimrat
Journal:  J Anat       Date:  2007-05       Impact factor: 2.610

7.  Nitrative thioredoxin inactivation as a cause of enhanced myocardial ischemia/reperfusion injury in the aging heart.

Authors:  Hangxiang Zhang; Ling Tao; Xiangying Jiao; Erhe Gao; Bernard L Lopez; Theodore A Christopher; Walter Koch; Xin L Ma
Journal:  Free Radic Biol Med       Date:  2007-03-24       Impact factor: 7.376

8.  Myocardial ischemic reperfusion induces de novo Nrf2 protein translation.

Authors:  Beibei Xu; Jack Zhang; Joshua Strom; Sang Lee; Qin M Chen
Journal:  Biochim Biophys Acta       Date:  2014-06-08

Review 9.  Redox regulation of cell survival by the thioredoxin superfamily: an implication of redox gene therapy in the heart.

Authors:  Md Kaimul Ahsan; Istvan Lekli; Diptarka Ray; Junji Yodoi; Dipak K Das
Journal:  Antioxid Redox Signal       Date:  2009-11       Impact factor: 8.401

Review 10.  Molecular mechanisms and clinical implications of reversible protein S-glutathionylation.

Authors:  John J Mieyal; Molly M Gallogly; Suparna Qanungo; Elizabeth A Sabens; Melissa D Shelton
Journal:  Antioxid Redox Signal       Date:  2008-11       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.